Riyadh
Saudi Arabia · 3 retained evidence mentions
Source-grounded findings
Supporting evidence
| Type | Entity | Source evidence | Confidence | Extractor |
|---|---|---|---|---|
| population | Saudi Arabia, Riyadh | “METHODS: We conducted a cross-sectional observational study at King Fahad Medical City in Riyadh, Saudi Arabia. RESULTS: The cohort comprised 1,005 patients.” | 0.95 | saudi_context_rules_v1 |
| population | Saudi Arabia, Riyadh | “METHOD: This retrospective descriptive study included children who had been diagnosed with disseminated BCGitis and treated with an antimycobacterial regimen including moxifloxacin for more than two weeks from 2007 to 2017 at King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia. Moxifloxacin serum concentration level was determined in 5 patients.” | 0.95 | saudi_context_rules_v1 |
| population | Saudi Arabia, Riyadh | “Outcome of adult Saudi patients with childhood-onset systemic lupus erythematosus. OBJECTIVES: We aimed to describe the social, educational, employment and long-term clinical outcomes of adults with childhood-onset systemic lupus erythematosus (SLE) in a Saudi cohort. METHODS: All adult patients with childhood-onset SLE who were treated and had regular follow-up between 1990 and 2013 at King Faisal Specialist Hospital and Research Centre (KFSH-RC), Riyadh were included. Forty patients (83%) had renal involvement, 7 (15%) of them progressed to end stage renal disease, 5 patients underwent renal transplant, 2 failed the transplant and are currently on haemodialysis. CONCLUSIONS: Our cohort indicates that the outcome of adult Saudi patients with childhood-onset SLE was satisfactory and comparable to earlier reports.” | 0.95 | saudi_context_rules_v1 |